Accuray Incorporated
$0.46
▲
6.82%
2026-04-21 05:22:00
www.accuray.com
NMS: ARAY
Explore Accuray Incorporated stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$52.79 M
Current Price
$0.46
52W High / Low
$2.1 / $0.33
Stock P/E
—
Book Value
$0.45
Dividend Yield
—
ROCE
2.82%
ROE
-70.32%
Face Value
—
EPS
$-0.31
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
990
Beta
1.32
Debt / Equity
326.14
Current Ratio
1.47
Quick Ratio
0.92
Forward P/E
-13
Price / Sales
0.11
Enterprise Value
$179.24 M
EV / EBITDA
-105.44
EV / Revenue
0.41
Rating
None
Target Price
$2.52
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Leverage is relatively high.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Phaos Technology Holdings (Caym | $1.95 | — | — | — | 214.51% | -10.73% | $7.39 / $0.53 | $-0.06 |
| 2. | Integra LifeSciences Holdings Corporation | $11.16 | — | $875.54 M | — | 0.57% | -39.9% | $17.54 / $8.7 | $13.4 |
| 3. | SI-BONE, Inc. | $14.32 | — | $632.45 M | — | -10.47% | -10.97% | $21.89 / $12.15 | $4.07 |
| 4. | ClearPoint Neuro, Inc. | $11.16 | — | $349.74 M | — | -27.78% | -95.64% | $30.1 / $8.27 | $0.95 |
| 5. | Myomo, Inc. | $0.9 | — | $34.65 M | — | -47.54% | -86.24% | $4.99 / $0.6 | $0.3 |
| 6. | 20/20 Biolabs, Inc. | $1.71 | — | — | — | -253.94% | -5.03% | $50 / $1.51 | $0.01 |
| 7. | SANUWAVE Health, Inc. | $19.94 | 14.99 | $177.13 M | — | 25.36% | -166.66% | $46.59 / $16.27 | $0.19 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | |
|---|---|---|---|---|---|
| Sales | 102.24 M | 93.94 M | 127.54 M | 113.24 M | 116.17 M |
| Operating Profit | -5.49 M | -11.31 M | 4.23 M | 1.05 M | 4.71 M |
| Net Profit | -13.77 M | -21.68 M | 1.12 M | -1.3 M | 2.54 M |
| EPS in Rs | -0.12 | -0.18 | 0.01 | -0.01 | 0.02 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 458.5 M | 446.55 M | 447.61 M | 429.91 M |
| Operating Profit | 7.84 M | 0.5 M | 2.38 M | 8.15 M |
| Net Profit | -1.59 M | -15.54 M | -9.28 M | -5.35 M |
| EPS in Rs | -0.01 | -0.13 | -0.08 | -0.05 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 470.24 M | 468.63 M | 479.21 M | 472.85 M |
| Total Liabilities | 389.07 M | 423.54 M | 425.56 M | 419.66 M |
| Equity | 81.17 M | 45.08 M | 53.66 M | 53.19 M |
| Current Assets | 317.46 M | 323.24 M | 338.03 M | 350.89 M |
| Current Liabilities | 192.58 M | 195.27 M | 198.64 M | 208.86 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 2.86 M | -11.9 M | 15.54 M | -2.4 M |
| Investing CF | -8.52 M | -3.6 M | -12.68 M | -4.72 M |
| Financing CF | -4.25 M | -3.95 M | -2.11 M | -15.37 M |
| Free CF | -5.66 M | -15.51 M | 2.86 M | -7.12 M |
| Capex | -8.52 M | -3.6 M | -12.68 M | -4.72 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | -0.24% | 4.12% | — | — |
| Earnings Growth % | -67.51% | -73.56% | — | — |
| Profit Margin % | -3.48% | -2.07% | -1.24% | — |
| Operating Margin % | 0.11% | 0.53% | 1.9% | — |
| Gross Margin % | 32.01% | 34.4% | 37.21% | — |
| EBITDA Margin % | 1.28% | 1.87% | 2.71% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.